Copyright
©The Author(s) 2021.
World J Gastroenterol. May 7, 2021; 27(17): 1943-1958
Published online May 7, 2021. doi: 10.3748/wjg.v27.i17.1943
Published online May 7, 2021. doi: 10.3748/wjg.v27.i17.1943
Table 1 Summary of studies of incidence of germline BRCA mutations in unselected pancreatic cancer cohorts
Ref. | Year | Population | Cohort size (Number AJ) | Germline BRCA1 pathogenic mutation incidence (%) | Germline BRCA2 pathogenic mutation incidence (%) | Combined germline BRCA mutation Incidence |
Holter et al[23] | 2015 | North American | 306 (33) | 1.0% | 3.6% | 4.6% |
Brand et al[24] | 2018 | North American | 298 (26) | 1.3% | 1.3% | 2.6% |
Mizukami et al[25] | 2020 | Japanese | 1005 (-) | 1.7% | 2.5% | 4.2% |
Grant et al[6] | 2015 | North American | 290 (13) | 0.3% | 0.7% | 1% |
Lowery et al[26] | 2018 | North American | 615 (111) | 2.3% | 5.7% | 8% |
- Citation: Rosen MN, Goodwin RA, Vickers MM. BRCA mutated pancreatic cancer: A change is coming. World J Gastroenterol 2021; 27(17): 1943-1958
- URL: https://www.wjgnet.com/1007-9327/full/v27/i17/1943.htm
- DOI: https://dx.doi.org/10.3748/wjg.v27.i17.1943